Tool 03 · Layers 2A + 2B → Value Translation
Rep Economic Story Co-Pilot
Archetype or case profile in; a bias-aware cover argument and the matching Amneal packet out — for peer-to-peer reviews and prior-auth appeals. The cost number is the live model output. The clinical dossier is Amneal's, deep-linked from brekiyahcp.com.
How this is meant to be usedThe engine does not hand the rep a list of a prescriber's individual patients — that's the PhRMA-Code line we hold on the segmentation page and we hold it here too. Instead the rep picks an archetype from the shared vocabulary, or enters a case profile a prescriber has already described in-conversation. The output is a cover argument the rep wrote plus the Amneal-authored dossier the office sends.
Evidence · from cost model
$61,421 / yr avoided
3 documented ED escalations (~$7,200 in facility cost) plus modeled forward-year avoidance at 12 attacks/mo.
Diagnosed bias · from discovery
Budget-silo bias
Payers / medical directors · 128 signals detected on the Medicare Advantage decision path.
Chosen reframe
TCOC + Star measure framing
Lead with total cost of care and ED-utilization offset — not unit price. Cite Star / HEDIS-adjacent utilization measures directly.
Artifact 1 · Cover argumentwritten by the rep, not from Amneal
ready to copy
Artifact 2 · Amneal packet checklistdeep-linked from brekiyahcp.com
6 items · cluster path · PA-appeal packet
- clinicalSample Letter of Medical Necessity — Cluster HeadacheCustomizable template; the office fills in patient-specific clinical detail.
- coverageSample Letter of Appeal — Cluster HeadacheStaple behind the cover argument above; the two together are the appeal packet.
- coverageHow to Prescribe — 3-step specialty pharmacy flowSterling Specialty Pharmacy or Walgreens Specialty; both handle PA, LMN, and appeals end-to-end.
- financialHead Start Program — free product during a pending appealUp to 3 cartons over 90 days at no cost while the appeal is pending. New Rx to TC Script, LLC.
- financialPatient Assistance Program (uninsured / underinsured)Eligibility determined after complete application; financial-eligibility criteria apply.
- referenceFull Prescribing Information (including Boxed Warning)Required reference for both the appeal and the peer-to-peer discussion.
Why the splitThe cover argument is the part the engine does well — bias-aware, cost-grounded, payer-language. The clinical dossier the office actually staples behind it is Amneal's own peer-reviewed, legal-reviewed packet. The rep is the connective tissue, not a parallel content factory.